Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TaiDoc TechnologyTPE:4736 +1.99%75 EV-to-OCF is 8.91 as of Sep. 11, 2026, which is 22% below its 10-year median of 11.39. GuruFocus rates TPE:4736 with a GF Score™ of 75/100 and a GF Value™ of NT$111.08 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 850 Medical Devices & Instruments companies, TaiDoc Technology ranks worse than 51.76% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, TaiDoc Technology's Enterprise Value is NT$8,296 Mil.
TaiDoc Technology's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was NT$931 Mil. Therefore, TaiDoc Technology's EV-to-OCF for today is 8.91.
The historical rank and industry rank for TaiDoc Technology's EV-to-OCF or its related term are showing as below:
TPE:4736'
s EV-to-OCF Range Over the Past 10 Years
Min: 3.55 Med: 11.39 Max: 25.88
Current: 8.91
During the past 13 years, the highest EV-to-OCF of TaiDoc Technology was 25.88. The lowest was 3.55. And the median was 11.39.
TPE:4736's EV-to-OCF is ranked worse than 51.76% of 850
companies
in the Medical Devices & Instruments industry
Industry Median: 7.81
vs TPE:4736: 8.91
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
TaiDoc Technology's PE Ratio (TTM) for today is calculated as:
TaiDoc Technology's share price for today is NT$128.00.
TaiDoc Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$24.406.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
TaiDoc Technology EV-to-OCF Related Terms
TaiDoc Technology EV-to-OCF Historical Data
* Premium members only.
The historical data trend for TaiDoc Technology's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, TaiDoc Technology's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TaiDoc Technology EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, TaiDoc Technology's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where TaiDoc Technology's EV-to-OCF falls into.
TaiDoc Technology's current Enterprise Value is NT$8,296 Mil.
TaiDoc Technology's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$931 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TaiDoc Technology (TPE:4736) has a EV-to-OCF of 8.91 as of Sep. 11, 2026. This is 22% below median its historical median of 11.39. Over the past decade, TaiDoc Technology's EV-to-OCF has ranged from 3.55 to 25.88. According to the industry distribution chart, TaiDoc Technology ranks #440 out of 850 companies in the Medical Devices & Instruments industry, placing it in the top 51.8%.
Is TaiDoc Technology's EV-to-OCF too high?
TaiDoc Technology's current EV-to-OCF of 8.91 is 22% below median its 10-year median of 11.39. Over the past 10 years, this metric has ranged from a low of 3.55 to a high of 25.88. The Medical Devices & Instruments industry median EV-to-OCF is 7.81. TaiDoc Technology's value of 8.91 is 14.1% above this industry median. Based on the distribution chart, TaiDoc Technology ranks #440 out of 850 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, TaiDoc Technology has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does TaiDoc Technology's EV-to-OCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, TaiDoc Technology ranks #440 out of 850 companies for EV-to-OCF. This places TaiDoc Technology in the lower half of its industry. The industry median EV-to-OCF is 7.81. TaiDoc Technology's value of 8.91 is 14.1% above this benchmark. Historically, TaiDoc Technology's own EV-to-OCF has ranged from 3.55 to 25.88 over the past decade. While the company's 10-year median is 11.39 vs. the industry median of 7.81, TaiDoc Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.81, based on 850 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TaiDoc Technology's current EV-to-OCF of 8.91 is 14.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TaiDoc Technology's current EV-to-OCF is 8.91, which is 22% below median its own 10-year median of 11.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TaiDoc Technology stock overvalued right now?
Based on GuruFocus' analysis, TaiDoc Technology (TPE:4736) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$111.08, compared to a current price of NT$128.00 — trading 15.2% above its estimated fair value. The current EV-to-OCF is 8.91, which is 22% below median its 10-year median of 11.39 and 14.1% above the Medical Devices & Instruments industry median of 7.81. TaiDoc Technology's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For TaiDoc Technology (TPE:4736), the current EV-to-OCF is 8.91 as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TaiDoc Technology (TPE:4736) Overvalued in 2026?
Based on GuruFocus' analysis, TaiDoc Technology stock appears to be overvalued.
The current stock price of NT$128.00 is trading 15.2% above its estimated GF Value™ of NT$111.08.
GuruFocus considers TaiDoc Technology to be Modestly Overvalued.
Key valuation signals for TPE:4736:
EV-to-OCF: 8.91 (22% below median its 10-year median of 11.39)
GF Value™: NT$111.08 vs. price of NT$128.00 (15.2% above fair value)
Industry Position: 14.1% above the Medical Devices & Instruments median (#440 of 850)
No single metric tells the full story. See the TPE:4736 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TaiDoc Technology Corp is engaged in the research and development, manufacture, and sales of various electronics components and medical devices. Its products and services include In Vitro Diagnostic, Medical Device, and TeleHealth. It has three segments: Manufacturing of Medical Devices, Precision Finishing Division, and Sales of Medical Devices. It derives the majority of its revenue from the Manufacturing of Medical Devices. Geographically, the company derives its key revenue from Europe and the rest from the Americas, the Middle East, Asia, Taiwan, and others.
75GF Score
Get the complete analysis for TPE:4736
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4736 has been successfully added to your 
